Abstract
ABSTRACTSegregation of bacteria based on their metabolic activities in biofilms plays an important role in the development of antibiotic resistance. Mushroom-shaped biofilm structures, which are reported for many bacteria, exhibit topographically varying levels of multiple drug resistance from the cap of the mushroom to its stalk. Understanding the dynamics behind the formation of such structures can aid in design of drug delivery systems, antibiotics, or physical systems for removal of biofilms. We explored the development of metabolically heterogeneous Pseudomonas aeruginosa biofilms using numerical models and laboratory knockout experiments on wild-type and chemotaxis-deficient mutants. We show that chemotactic processes dominate the transformation of slender and hemispherical structures into mushroom structures with a signature cap. Cellular Potts model simulation and experimental data provide evidence that accelerated movement of bacteria along the periphery of the biofilm, due to nutrient cues, results in the formation of mushroom structures and bacterial segregation. Multidrug resistance of bacteria is one of the most threatening dangers to public health. Understanding the mechanisms of the development of mushroom-shaped biofilms helps to identify the multidrug-resistant regions. We decoded the dynamics of the structural evolution of bacterial biofilms and the physics behind the formation of biofilm structures as well as the biological triggers that produce them. Combining in vitro gene knockout experiments with in silico models showed that chemotactic motility is one of the main driving forces for the formation of stalks and caps. Our results provide physicists and biologists with a new perspective on biofilm removal and eradication strategies.
Highlights
Bacteria thrive in natural environments using two modes of growth, (i) planktonic growth by independent, single bacteria and (ii) biofilm growth, in which the cells function as a group
It has been shown that dormant bacteria are resistant to antibiotic treatments; the segregation of bacteria into different states within the biofilm will lead to differential drug resistance expression at different regions [7]
If a mixture of two strains of P. aeruginosa bacteria, e.g., a wild type with motility and a nonmotile mutant, are cultured together, mushroom structures are formed with the wild-type motile bacteria on the cap of the mushroom and the nonmotile mutants occupying the stalk of the mushroom [19]
Summary
Bacteria thrive in natural environments using two modes of growth, (i) planktonic growth by independent, single bacteria and (ii) biofilm growth, in which the cells function as a group. Cells present at the top or cap of mushroom-shaped biofilms have been shown to be resistant to colistin [5]. Cells within or on the stalk of mushroom-shaped biofilms, have shown resistance to carbapenems and tobramycin [6].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have